← Open Payments lookup

COURTNEY MCCONNELL: Open Payments

NPI 1497476048 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,588 in 204 payments from 26 companies in 2025. Trend: 2023 $0 · 2024 $3,356 · 2025 $5,588

Food & beverage: $5,322Education: $170Consulting: $95
CompanyPaymentsAmount
Regeneron Healthcare Solutions, Inc.29$941
AstraZeneca Pharmaceuticals LP23$726
GENZYME CORPORATION15$533
Pharming Healthcare, Inc.11$433
GlaxoSmithKline, LLC.20$402
Takeda Pharmaceuticals U.S.A., Inc.19$400
LEO Pharma Inc.6$294
ARS Pharmaceuticals Operations, Inc.8$259
Novartis Pharmaceuticals Corporation8$253
ABBVIE INC.6$211

Products named: DUPIXENT, RUCONEST, FASENRA, NEFFY, ANZUPGO, AIRSUPRA, NUCALA, TEZSPIRE.

Industry payments across NV — which companies pay providers there.